These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 1361324)

  • 21. A potent antioxidant, SB209995, inhibits oxygen-radical-mediated lipid peroxidation and cytotoxicity.
    Feuerstein R; Yue TL
    Pharmacology; 1994 Jun; 48(6):385-91. PubMed ID: 8047557
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structure-function relationships of calcium antagonists. Effect on oxidative modification of low density lipoprotein.
    Rojstaczer N; Triggle DJ
    Biochem Pharmacol; 1996 Jan; 51(2):141-50. PubMed ID: 8615882
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lipophilic beta-blockers inhibit monocyte and endothelial cell-mediated modification of low density lipoproteins.
    Mazière C; Auclair M; Mazière JC
    Biochim Biophys Acta; 1992 Jun; 1126(3):314-8. PubMed ID: 1353372
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vasodilating mechanism and response to physiological pressor stimuli of acute doses of carvedilol compared with labetalol, propranolol and hydralazine.
    Tomlinson B; Bompart F; Graham BR; Liu JB; Prichard BN
    Drugs; 1988; 36 Suppl 6():37-47. PubMed ID: 2908303
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Therapeutic dose of nebivolol, a nitric oxide-releasing beta-blocker, reduces atherosclerosis in cholesterol-fed rabbits.
    de Nigris F; Mancini FP; Balestrieri ML; Byrns R; Fiorito C; Williams-Ignarro S; Palagiano A; Crimi E; Ignarro LJ; Napoli C
    Nitric Oxide; 2008 Aug; 19(1):57-63. PubMed ID: 18435936
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel 3,5-diaryl pyrazolines and pyrazole as low-density lipoprotein (LDL) oxidation inhibitor.
    Jeong TS; Kim KS; Kim JR; Cho KH; Lee S; Lee WS
    Bioorg Med Chem Lett; 2004 Jun; 14(11):2719-23. PubMed ID: 15125921
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inducible nitric oxide synthase knockout mouse macrophages disclose prooxidant effect of interferon-gamma on low-density lipoprotein oxidation.
    Niu XL; Xia Y; Hoshiai K; Tanaka K; Sawamura S; Nakazawa H
    Nitric Oxide; 2000 Aug; 4(4):363-71. PubMed ID: 10944420
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Melatonin inhibits oxidative modification of human low-density lipoprotein.
    Kelly MR; Loo G
    J Pineal Res; 1997 May; 22(4):203-9. PubMed ID: 9247205
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Carvedilol and its metabolites suppress endothelin-1 production in human endothelial cell culture.
    Saijonmaa O; Metsärinne K; Fyhrquist F
    Blood Press; 1997 Jan; 6(1):24-8. PubMed ID: 9116922
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Carvedilol inhibits vascular smooth muscle cell proliferation.
    Sung CP; Arleth AJ; Ohlstein EH
    J Cardiovasc Pharmacol; 1993 Feb; 21(2):221-7. PubMed ID: 7679155
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low-density lipoprotein (LDL)-antioxidant lignans from Myristica fragrans seeds.
    Kwon HS; Kim MJ; Jeong HJ; Yang MS; Park KH; Jeong TS; Lee WS
    Bioorg Med Chem Lett; 2008 Jan; 18(1):194-8. PubMed ID: 17998162
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Carvedilol, a new antihypertensive drug with unique antioxidant activity: potential role in cerebroprotection.
    Yue TL; Lysko PG; Barone FC; Gu JL; Ruffolo RR; Feuerstein GZ
    Ann N Y Acad Sci; 1994 Nov; 738():230-42. PubMed ID: 7832432
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of low density lipoprotein oxidation in vitro by the 6- and 7-hydroxy-metabolites of doxazosin, an alpha 1-adrenergic antihypertensive agent.
    Chait A; Gilmore M; Kawamura M
    Am J Hypertens; 1994 Feb; 7(2):159-67. PubMed ID: 8179851
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glycation accelerates the oxidation of low density lipoprotein by copper ions.
    Kobayashi K; Watanabe J; Umeda F; Nawata H
    Endocr J; 1995 Aug; 42(4):461-5. PubMed ID: 8556051
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A critical assessment of the effects of aminoguanidine and ascorbate on the oxidative modification of LDL: evidence for interference with some assays of lipoprotein oxidation by aminoguanidine.
    Scaccini C; Chiesa G; Jialal I
    J Lipid Res; 1994 Jun; 35(6):1085-92. PubMed ID: 8077847
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antioxidant alpha-keto-carboxylate pyruvate protects low-density lipoprotein and atherogenic macrophages.
    Kang YH; Park SH; Lee YJ; Kang JS; Kang IJ; Shin HK; Park JH; Bünger R
    Free Radic Res; 2002 Aug; 36(8):905-14. PubMed ID: 12420749
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hibiscus anthocyanins-rich extract inhibited LDL oxidation and oxLDL-mediated macrophages apoptosis.
    Chang YC; Huang KX; Huang AC; Ho YC; Wang CJ
    Food Chem Toxicol; 2006 Jul; 44(7):1015-23. PubMed ID: 16473450
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential effects of bucindolol and carvedilol on noradenaline-induced hypertrophic response in ventricular cardiomyocytes of adult rats.
    Pönicke K; Heinroth-Hoffmann I; Brodde OE
    J Pharmacol Exp Ther; 2002 Apr; 301(1):71-6. PubMed ID: 11907159
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of resveratrol on oxidative modification of human low density lipoprotein.
    Zou J; Huang Y; Chen Q; Wei E; Cao K; Wu JM
    Chin Med J (Engl); 2000 Feb; 113(2):99-102. PubMed ID: 11775553
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pleiotropic effects of the beta-adrenoceptor blocker carvedilol on calcium regulation during oxidative stress-induced apoptosis in cardiomyocytes.
    Wang R; Miura T; Harada N; Kametani R; Shibuya M; Fukagawa Y; Kawamura S; Ikeda Y; Hara M; Matsuzaki M
    J Pharmacol Exp Ther; 2006 Jul; 318(1):45-52. PubMed ID: 16611853
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.